VistaPharm, Inc. recalls Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 666…
- Recall date
- January 7, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0376-2022
- FDA classification
- Class II
- Brand / firm
- VistaPharm, Inc.
- Sold / distributed
- Nationwide within the United States including Puerto Rico
Why it was recalled
Failed Stability Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
Get recall alerts
Free email alert whenever VistaPharm, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: VistaPharm, Inc.